Xuejie Chen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Protein Protein

Patient Reported Outcomes

Venous Thromboembolism

Top Venues

Nature communications

Journal of thrombosis and haemostasis : JTH

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Da-Yun Jin, Xuejie Chen, Yizhou Liu, Craig M Williams, Lars C Pedersen, Darrel W Stafford, Jian-Ke Tie
A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nature communications 14 (1) (2023)
Da-Yun Jin, Xuejie Chen, Yizhou Liu, Craig M Williams, Lars C Pedersen, Darrel W Stafford, Jian-Ke Tie
A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nature communications 14 (1) (2023)
Da-Yun Jin, Xuejie Chen, Yizhou Liu, Craig M Williams, Lars C Pedersen, Darrel W Stafford, Jian-Ke Tie
A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nature communications 14 (1) (2023)
Da-Yun Jin, Xuejie Chen, Yizhou Liu, Craig M Williams, Lars C Pedersen, Darrel W Stafford, Jian-Ke Tie
A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nature communications 14 (1) (2023)
Xuejie Chen, Natsuko Furukawa, Da-Yun Jin, Yizhou Liu, Darrel W Stafford, Craig M Williams, Yoshitomo Suhara, Jian-Ke Tie
Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation. The FEBS journal (2021)
Xuejie Chen, Yizhou Liu, Natsuko Furukawa, Da-Yun Jin, G Paul Savage, Darrel W Stafford, Yoshitomo Suhara, Craig M Williams, Jian-Ke Tie
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase. Journal of thrombosis and haemostasis : JTH 19 (3) (2021)